@FierceBiotech: Icon signs up to boost Taiwan's stake in drug development. FierceCRO article | Release | Follow @FierceBiotech
@JohnCFierce: If Roche does try to buy Alexion, the company is going to get slaughtered by the analysts. More | Follow @JohnCFierce
@RyanMFierce: CollabRx elbows into software game for gene interpretation. FierceBiotech IT story | Follow @RyanMFierce
@EmilyMFierce: Newly discovered proteins could play role in destroying cancer cells. More from FierceBiotech Research | Follow @EmilyMFierce
> Royalty Pharma sold about 20% of the royalty interest in ibrutinib it recently acquired from Quest Diagnostics ($DGX) to Aisling and Clarus. Release
> Australia's ABC reports that a cancer drug study has been suspended pending an investigation of the science and data that underpin the compound DZ13. Story
@FierceMedDev: Kona snags ex-SonoSite exec to helm renal denervation. Article | Follow @FierceMedDev
@DamianFierce: Medtronic is spending $200M on a telehealth outfit with an eye on slashing healthcare costs. News | Follow @DamianFierce
@MichaelGFierce: New antivirus system could protect medical devices from infection. Article | Follow @MichaelGFierce
> Agilent, SomaLogic team up on Dx technology. Item
> Montreal's EMcision launches catheters for pancreatic cancer. More
Pharma News
@FiercePharma: Still trending: Pharma professionals feeling angst, but see a few rays of hope. Story | Follow @FiercePharma
@EricPFierce: India's Aurobindo puts sterile injectables unit into a subsidiary to unlock value. Wonder if it will shop it next? Story | Follow @EricPFierce
@CarlyHFierce: Sanofi's statement on the latest bribery allegations in China: Statement | Follow @CarlyHFierce
> Roche chief's comments about deal discipline push shares up. Item
> LAT: Purdue keeps 'risky' OxyContin prescribers' names private. Article
> Sanofi 'confident' about China ops as officials launch bribery probe. Report
CRO News
> Covance offers service to keep contracts under control. Item
> ScinoPharm, Sundia team up in China. Report
> Parexel bets big on the future as revenue swells. Story
> AMRI swings to red despite another sales jump. More
> InVentiv takes aim at blockbusters with biosimilar deal. Article
Biotech IT News
> Medidata to score $287.5M in major financing. News
> CollabRx elbows into software game for gene interpretation. More
> Roche rolls out updated software for next-generation sequencing. Report
> Big Data analysis outfit GNS teams with Inova on predicting preterm birth. Story
> Gene by Gene acquires software upstart Arpeggi. Article
Blog watch: Xconomy's Luke Timmerman concludes that the idea of rewarding scientists with big bonuses for their drug research is a bad idea. Blog